CN114736938A - A hypoxia-responsive alkyne-amine click polymerization method for intracellular polymerization and its application - Google Patents
A hypoxia-responsive alkyne-amine click polymerization method for intracellular polymerization and its application Download PDFInfo
- Publication number
- CN114736938A CN114736938A CN202210278516.7A CN202210278516A CN114736938A CN 114736938 A CN114736938 A CN 114736938A CN 202210278516 A CN202210278516 A CN 202210278516A CN 114736938 A CN114736938 A CN 114736938A
- Authority
- CN
- China
- Prior art keywords
- polymerization
- cells
- hypoxia
- amine
- alkyne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010021143 Hypoxia Diseases 0.000 title claims abstract description 66
- 238000006116 polymerization reaction Methods 0.000 title claims abstract description 61
- 230000007954 hypoxia Effects 0.000 title claims abstract description 44
- 230000003834 intracellular effect Effects 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 27
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 29
- -1 alkynyl compound Chemical class 0.000 claims abstract description 25
- 150000002828 nitro derivatives Chemical class 0.000 claims abstract description 24
- 230000001146 hypoxic effect Effects 0.000 claims abstract description 22
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000001301 oxygen Substances 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 123
- 239000002953 phosphate buffered saline Substances 0.000 claims description 63
- 239000000243 solution Substances 0.000 claims description 50
- 239000001963 growth medium Substances 0.000 claims description 31
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 26
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 21
- 239000002609 medium Substances 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 18
- 238000000799 fluorescence microscopy Methods 0.000 claims description 15
- 210000004881 tumor cell Anatomy 0.000 claims description 10
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 5
- 239000007995 HEPES buffer Substances 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 238000006467 substitution reaction Methods 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 229910001873 dinitrogen Inorganic materials 0.000 claims 1
- 230000007959 normoxia Effects 0.000 abstract description 35
- 102000004459 Nitroreductase Human genes 0.000 abstract description 9
- 108020001162 nitroreductase Proteins 0.000 abstract description 9
- 230000002829 reductive effect Effects 0.000 abstract description 5
- 238000012258 culturing Methods 0.000 abstract description 3
- 150000003384 small molecules Chemical class 0.000 abstract description 3
- 238000004873 anchoring Methods 0.000 abstract description 2
- 238000012632 fluorescent imaging Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 33
- 229940125904 compound 1 Drugs 0.000 description 25
- 150000001345 alkine derivatives Chemical class 0.000 description 23
- 239000012091 fetal bovine serum Substances 0.000 description 18
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 16
- 150000004985 diamines Chemical class 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 239000006143 cell culture medium Substances 0.000 description 12
- 231100000820 toxicity test Toxicity 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 10
- 230000007326 intracellular aggregation Effects 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- 238000011534 incubation Methods 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- DOBMPNYZJYQDGZ-UHFFFAOYSA-N dicoumarol Chemical compound C1=CC=CC2=C1OC(=O)C(CC=1C(OC3=CC=CC=C3C=1O)=O)=C2O DOBMPNYZJYQDGZ-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 238000001308 synthesis method Methods 0.000 description 4
- 230000004614 tumor growth Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229960001912 dicoumarol Drugs 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 102000004082 Calreticulin Human genes 0.000 description 2
- 108090000549 Calreticulin Proteins 0.000 description 2
- 108010040476 FITC-annexin A5 Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 238000010226 confocal imaging Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000013861 fat-free Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 108090000672 Annexin A5 Proteins 0.000 description 1
- 102000004121 Annexin A5 Human genes 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000235 effect on cancer Effects 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- JLZUZNKTTIRERF-UHFFFAOYSA-N tetraphenylethylene Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)=C(C=1C=CC=CC=1)C1=CC=CC=C1 JLZUZNKTTIRERF-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明提供了一种乏氧响应型炔‑胺点击聚合的细胞内聚合方法及其应用,属于生物化学技术领域。本发明提供的乏氧响应型炔‑胺点击聚合的细胞内聚合方法,包括如下步骤:(1)将细胞在二元硝基化合物溶液中进行乏氧培养;(2)将步骤(1)乏氧培养后的细胞转至二元炔基化合物溶液中进行常氧培养;(3)步骤(2)常氧培养后的细胞转至培养基中常氧培养,即实现乏氧响应型炔‑胺点击聚合的细胞内聚合。本发明中的二元硝基化合物通过细胞内的硝基还原酶在乏氧条件下还原为二元胺基化合物,还原后的二元胺基化合物与二元炔基化合物在细胞内进行聚合,从而实现对荧光小分子的锚定,导致荧光信号“点亮”,实现细胞的荧光成像。
The invention provides an intracellular polymerization method of hypoxia-responsive alkyne-amine click polymerization and application thereof, belonging to the technical field of biochemistry. The intracellular polymerization method of hypoxia-responsive alkyne-amine click polymerization provided by the present invention includes the following steps: (1) culturing cells in a binary nitro compound solution under hypoxia; The cells after the oxygen culture are transferred to the binary alkynyl compound solution for normoxia culture; (3) step (2) the cells after the normoxia culture are transferred to the medium for normoxia culture, that is, the hypoxia-responsive alkynylamine click is realized Aggregate intracellular aggregates. The dibasic nitro compound in the present invention is reduced to a dibasic amine compound by the intracellular nitroreductase under hypoxic conditions, and the reduced dibasic amine compound and the dibasic alkynyl compound are polymerized in the cell, In this way, the anchoring of fluorescent small molecules is realized, resulting in the "lighting up" of the fluorescent signal, and the fluorescent imaging of cells is realized.
Description
技术领域technical field
本发明涉及生物化学技术领域,尤其涉及一种乏氧响应型炔-胺点击聚合的细胞内聚合方法及其应用。The invention relates to the technical field of biochemistry, in particular to an intracellular polymerization method of hypoxia-responsive alkyne-amine click polymerization and application thereof.
背景技术Background technique
2014年,唐本忠院士课题在扩展基于炔类单体的点击聚合过程中,建立了一种无需催化剂、自发进行的巯基-炔点击聚合反应。该反应可以在非常温和的条件下进行,而无需使用外部催化剂。短短2小时获得高分子量聚合物且产量高达97%(Macromalecules,2014,47:1325-1333)。但是,在组织细胞内构建炔-胺点击聚合反应时,羰基活化的炔类单体与四苯基乙烯(TPE)的双胺可以同时被正常细胞和肿瘤细胞摄取,并自发地发生细胞内聚合而实现“点亮”成像,这样便难以区分正常细胞和肿瘤细胞。In 2014, in the process of expanding the click polymerization process based on alkyne monomers, the project of Academician Tang Benzhong established a spontaneous thiol-alkyne click polymerization reaction without catalyst. The reaction can be carried out under very mild conditions without the use of external catalysts. High molecular weight polymers were obtained in as little as 2 hours with yields as high as 97% (Macromalecules, 2014, 47: 1325-1333). However, when alkyne-amine click polymerization is constructed in tissue cells, carbonyl-activated alkyne monomers and diamines of tetraphenylethylene (TPE) can be taken up by normal cells and tumor cells at the same time, and spontaneously undergo intracellular polymerization. To achieve "light-on" imaging, it is difficult to distinguish between normal cells and tumor cells.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种乏氧响应型炔-胺点击聚合的细胞内聚合方法及其应用,实现精准定位肿瘤细胞。The purpose of the present invention is to provide an intracellular polymerization method of hypoxia-responsive alkyne-amine click polymerization and its application, so as to achieve precise localization of tumor cells.
为了实现上述发明目的,本发明提供以下技术方案:In order to achieve the above-mentioned purpose of the invention, the present invention provides the following technical solutions:
本发明提供了一种乏氧响应型炔-胺点击聚合的细胞内聚合方法,包括如下步骤:The invention provides an intracellular polymerization method of hypoxia-responsive alkyne-amine click polymerization, comprising the following steps:
(1)将细胞在二元硝基化合物溶液中进行乏氧培养;(1) Hypoxic culture of cells in binary nitro compound solution;
(2)将步骤(1)乏氧培养后的细胞转至二元炔基化合物溶液中进行常氧培养;(2) transferring the cells after the hypoxic culture in step (1) to a binary alkynyl compound solution for normoxia culture;
(3)步骤(2)常氧培养后的细胞转至培养基中常氧培养,即实现乏氧响应型炔-胺点击聚合的细胞内聚合;(3) In step (2), the cells after the normoxia culture are transferred to the culture medium for normoxia culture, that is, the intracellular polymerization of the hypoxia-responsive alkyne-amine click polymerization is realized;
步骤(1)中所述乏氧培养的氧气浓度为1~20%。The oxygen concentration of the hypoxic culture in step (1) is 1-20%.
优选的,所述二元硝基化合物的结构式为 Preferably, the structural formula of the binary nitro compound is
所述二元炔基化合物的结构式为 The structural formula of the binary alkynyl compound is
式(Ⅰ)~(Ⅲ)中,R1,R3选自(1)~(18)中的任意一种;R2,R4选自氢原子或(19)~(22)中的任意一种或几种:In formulas (I) to (III), R 1 and R 3 are selected from any one of (1) to (18); R 2 and R 4 are selected from hydrogen atoms or any of (19) to (22). One or more of:
其中,m、h、k为1~100整数;X选自N、P、O、S或Si元素;*表示取代位置。Wherein, m, h and k are integers from 1 to 100; X is selected from N, P, O, S or Si elements; * represents a substitution position.
优选的,所述二元硝基化合物溶液的浓度为0.1μmol/L~150mmol/L。Preferably, the concentration of the binary nitro compound solution is 0.1 μmol/L˜150 mmol/L.
优选的,所述细胞的浓度为1×105~2×105个/mL。Preferably, the concentration of the cells is 1×10 5 to 2×10 5 cells/mL.
优选的,所述细胞为肿瘤细胞。Preferably, the cells are tumor cells.
优选的,所述二元炔基化合物溶液的浓度为1μmol/L~100mmol/L。Preferably, the concentration of the binary alkynyl compound solution is 1 μmol/L˜100 mmol/L.
优选的,所述二元硝基化合物溶液的溶剂、二元炔基化合物溶液的溶剂和步骤(3)中所述培养基独立的为PBS磷酸缓冲盐溶液、HEPES缓冲液、DMEM细胞培养基和1640细胞培养基中的一种。Preferably, the solvent of the binary nitro compound solution, the solvent of the binary alkynyl compound solution and the medium in step (3) are independently PBS phosphate buffered saline, HEPES buffer, DMEM cell culture medium and One of the 1640 cell culture media.
优选的,步骤(1)中所述乏氧培养和步骤(2)、(3)中所述常氧培养的温度独立的为4~37℃,时间独立的为1~600min。Preferably, the temperature of the hypoxic culture in step (1) and the normoxic culture in steps (2) and (3) are independently 4-37° C., and the time is independently 1-600 min.
本发明还提供了一种所述的乏氧响应型炔-胺点击聚合的细胞内聚合方法实现细胞荧光成像的应用。The invention also provides an application of the hypoxia-responsive intracellular polymerization method of alkyne-amine click polymerization to realize cell fluorescence imaging.
本发明提供的乏氧响应型炔-胺点击聚合的细胞内聚合方法,利用了炔-胺点击聚合的反应高效、条件温和等优点,可以实现细胞内的荧光成像。本发明中的二元硝基化合物由于硝基猝灭效应使得二元硝基化合物不发光或发光很弱,但是二元硝基化合物通过细胞内的硝基还原酶在乏氧条件下被还原为二元胺基化合物后,二元胺基化合物发光较强。然后二元胺基化合物与二元炔基化合物在细胞内进行聚合,从而实现对荧光小分子的锚定,导致荧光信号“点亮”,实现细胞的荧光成像。进一步的,又因为肿瘤细胞内硝基还原酶相对于正常组织细胞高表达,因此正常细胞中的二元胺基化合物的浓度相对较低,荧光成像相对较弱,从而将其与具有较强荧光成像的肿瘤细胞进行区分。本发明的上述研究成果可以用于体外细胞的乏氧分析研究。The hypoxia-responsive intracellular polymerization method of alkyne-amine click polymerization provided by the invention utilizes the advantages of high reaction efficiency and mild conditions of alkyne-amine click polymerization, and can realize intracellular fluorescence imaging. The binary nitro compound in the present invention does not emit light or emits very weak light due to the nitro quenching effect, but the binary nitro compound is reduced by the intracellular nitroreductase under hypoxic conditions to After the diamine-based compound, the diamine-based compound emits stronger light. Then the diamine-based compound and the dibasic alkynyl compound are polymerized in the cell, so as to realize the anchoring of the fluorescent small molecule, resulting in the "lighting" of the fluorescent signal, and realizing the fluorescence imaging of the cell. Further, because nitroreductase is highly expressed in tumor cells compared with normal tissue cells, the concentration of diamine-based compounds in normal cells is relatively low, and the fluorescence imaging is relatively weak, which is compared with those with strong fluorescence. Image the tumor cells to differentiate. The above research results of the present invention can be used for hypoxia analysis research of in vitro cells.
附图说明Description of drawings
图1为实施例2中化合物1和化合物M1的荧光光谱图;Fig. 1 is the fluorescence spectrogram of
图2为实施例3中乏氧响应型细胞内聚合在21%O2、5%O2和1%O2以及5%O2+双香豆素预孵育后的激光共聚焦显微镜成像图;Fig. 2 is a confocal laser microscope image of hypoxia-responsive intracellular aggregation pre-incubated in 21% O 2 , 5% O 2 and 1% O 2 and 5% O 2 + dicoumarin in Example 3;
图3为实施例4中正常细胞(L929)与癌细胞(4T1、A549和HeLa)经乏氧响应型细胞内聚合处理后的激光共聚焦荧光图;Fig. 3 is the laser confocal fluorescence image of normal cells (L929) and cancer cells (4T1, A549 and HeLa) treated by hypoxia-responsive intracellular polymerization in Example 4;
图4为实施例5中有无化合物M2对乏氧响应型细胞内聚合的影响,其中,(A)为化合物1孵育后不加化合物M2的荧光成像,(B)为化合物1孵育后加化合物M2的荧光成像;Figure 4 shows the effect of compound M2 on hypoxia-responsive intracellular aggregation in Example 5, wherein (A) is the fluorescence imaging of
图5为实施例6中化合物1对HaLe细胞的毒性测试结果;Fig. 5 is the toxicity test result of
图6为实施例6中化合物M2对HaLe细胞的毒性测试结果;Fig. 6 is the toxicity test result of compound M2 to HaLe cell in
图7为实施例6中乏氧响应型细胞内聚合对HaLe细胞的毒性测试结果;Fig. 7 is the toxicity test result of hypoxia-responsive intracellular polymerization to HaLe cells in Example 6;
图8为实施例6中空白组和乏氧响应型细胞内聚合(实验组)的HeLa细胞扫描电镜表征图;8 is a scanning electron microscope characterization diagram of HeLa cells in the blank group and hypoxia-responsive intracellular aggregation (experimental group) in Example 6;
图9为实施例6中空白组和乏氧响应型细胞内聚合(实验组)的HeLa细胞冷冻电镜表征图;FIG. 9 is a cryo-electron microscope characterization diagram of HeLa cells in the blank group and hypoxia-responsive intracellular aggregation (experimental group) in Example 6;
图10为实施例7中空白组和乏氧响应型细胞内聚合(实验组)的HeLa细胞与钙网蛋白共染的激光共聚焦显微镜成像图;10 is a confocal laser microscope image of HeLa cells co-stained with calreticulin in the blank group and hypoxia-responsive intracellular aggregation (experimental group) in Example 7;
图11为实施例8中空白组和乏氧响应型细胞内聚合(实验组)的HeLa细胞与Annexin V和PI共染的激光共聚焦显微镜成像图;Figure 11 is a confocal laser microscope image of HeLa cells co-stained with Annexin V and PI in the blank group and hypoxia-responsive intracellular aggregation (experimental group) in Example 8;
图12为实施例9中小鼠的肿瘤体积变化;Figure 12 is the tumor volume change of mice in Example 9;
图13为实施例9中小鼠的体重变化。FIG. 13 shows changes in body weight of mice in Example 9. FIG.
具体实施方式Detailed ways
本发明提供了一种乏氧响应型炔-胺点击聚合的细胞内聚合方法,包括如下步骤:The invention provides an intracellular polymerization method of hypoxia-responsive alkyne-amine click polymerization, comprising the following steps:
(1)将细胞在二元硝基化合物溶液中进行乏氧培养;(1) Hypoxic culture of cells in binary nitro compound solution;
(2)将步骤(1)乏氧培养后的细胞转至二元炔基化合物溶液中进行常氧培养;(2) transferring the cells after the hypoxic culture in step (1) to a binary alkynyl compound solution for normoxia culture;
(3)步骤(2)常氧培养后的细胞转至培养基中常氧培养,即实现乏氧响应型炔-胺点击聚合的细胞内聚合;(3) In step (2), the cells after the normoxia culture are transferred to the culture medium for normoxia culture, that is, the intracellular polymerization of the hypoxia-responsive alkyne-amine click polymerization is realized;
步骤(1)中所述乏氧培养的氧气浓度为1~20%。The oxygen concentration of the hypoxic culture in step (1) is 1-20%.
本发明将细胞与二元硝基化合物溶液混合后,进行乏氧培养。In the present invention, the cells are mixed with the binary nitro compound solution to carry out hypoxic culture.
在本发明中,步骤(1)中所述乏氧培养的氧气浓度为1~20%,优选为3~10%,进一步优选为5%。In the present invention, the oxygen concentration of the hypoxic culture in step (1) is 1-20%, preferably 3-10%, more preferably 5%.
在本发明中,所述二元硝基化合物的结构式优选为所述二元炔基化合物的结构式优选为 In the present invention, the structural formula of the binary nitro compound is preferably The structural formula of the binary alkynyl compound is preferably
式(Ⅰ)~(Ⅲ)中,R1,R3选自(1)~(18)中的任意一种;R2,R4选自氢原子或(19)~(22)中的任意一种或几种:In formulas (I) to (III), R 1 and R 3 are selected from any one of (1) to (18); R 2 and R 4 are selected from hydrogen atoms or any of (19) to (22). One or more of:
其中,m、h、k为1~100整数;X选自N、P、O、S或Si元素;*表示取代位置。Wherein, m, h and k are integers from 1 to 100; X is selected from N, P, O, S or Si elements; * represents a substitution position.
在本发明中,所述细胞优选为肿瘤细胞,所述肿瘤细胞进一步优选为HeLa细胞。In the present invention, the cells are preferably tumor cells, and the tumor cells are more preferably HeLa cells.
在本发明中,所述细胞的浓度优选为1×105~2×105个/mL,进一步优选为1.5×105个/mL。In the present invention, the concentration of the cells is preferably 1×10 5 to 2×10 5 cells/mL, and more preferably 1.5×10 5 cells/mL.
在本发明中,所述二元硝基化合物溶液的浓度优选为0.1μmol/L~150mmol/L,进一步优选为1μmol/L~1500μmol/L,再进一步优选为150μmol/L。In the present invention, the concentration of the binary nitro compound solution is preferably 0.1 μmol/L to 150 mmol/L, more preferably 1 μmol/L to 1500 μmol/L, and still more preferably 150 μmol/L.
在本发明中,所述二元硝基化合物溶液的溶剂优选为PBS磷酸缓冲盐溶液、HEPES缓冲液、DMEM细胞培养基和1640细胞培养基中的一种或几种,进一步优选为PBS磷酸缓冲盐溶液或DMEM细胞培养基,再进一步优选为含10%胎牛血清的DMEM细胞培养基。In the present invention, the solvent of the binary nitro compound solution is preferably one or more of PBS phosphate buffered saline solution, HEPES buffer, DMEM cell culture medium and 1640 cell culture medium, more preferably PBS phosphate buffered saline Salt solution or DMEM cell culture medium, still more preferably DMEM cell culture medium containing 10% fetal bovine serum.
在本发明中,所述乏氧培养的温度优选为4~37℃,进一步优选为37℃。In the present invention, the temperature of the hypoxic culture is preferably 4 to 37°C, more preferably 37°C.
在本发明中,所述乏氧培养的时间优选为1~600min,进一步优选为60~180min,再进一步优选为120min。In the present invention, the time of the hypoxic culture is preferably 1-600 min, more preferably 60-180 min, and still more preferably 120 min.
在本发明中,所述细胞在二元硝基化合物溶液中培养结束后,弃去培养液,优选采用PBS磷酸缓冲盐溶液洗涤细胞。In the present invention, after the cells are cultured in the binary nitro compound solution, the culture medium is discarded, and the cells are preferably washed with PBS phosphate buffered saline.
在本发明中,所述PBS磷酸缓冲盐溶液的用量优选为0.5~1.5ml,进一步优选为1ml。In the present invention, the dosage of the PBS phosphate buffered saline solution is preferably 0.5-1.5 ml, more preferably 1 ml.
在本发明中,所述PBS磷酸缓冲盐溶液洗涤的次数优选为2~4次,进一步优选为3次。In the present invention, the number of times of washing with the PBS phosphate buffered saline solution is preferably 2 to 4 times, more preferably 3 times.
然后,将洗涤后的细胞与二元炔基化合物溶液混合,进行常氧培养。Then, the washed cells were mixed with a binary alkynyl compound solution to perform normoxia culture.
在本发明中,所述二元炔基化合物溶液的浓度优选为1μmol/L~100mmol/L,进一步优选为5μmol/L~1000μmol/L,再进一步优选为10μmol/L。In the present invention, the concentration of the binary alkynyl compound solution is preferably 1 μmol/L to 100 mmol/L, more preferably 5 μmol/L to 1000 μmol/L, and still more preferably 10 μmol/L.
在本发明中,所述二元炔基化合物溶液的溶质优选为PBS磷酸缓冲盐溶液、HEPES缓冲液、DMEM细胞培养基和1640细胞培养基中的一种或几种,进一步优选为PBS磷酸缓冲盐溶液或DMEM细胞培养基,再进一步优选为PBS磷酸缓冲盐溶液。In the present invention, the solute of the binary alkynyl compound solution is preferably one or more of PBS phosphate buffered saline solution, HEPES buffer, DMEM cell culture medium and 1640 cell culture medium, more preferably PBS phosphate buffer Saline solution or DMEM cell culture medium, still more preferably PBS phosphate buffered saline.
在本发明中,所述常氧培养的温度优选为4℃~37℃,进一步优选为37℃。In the present invention, the temperature of the normoxia culture is preferably 4°C to 37°C, more preferably 37°C.
在本发明中,所述常氧培养的时间优选为1~600min,进一步优选为5~30min,再进一步优选为10min。In the present invention, the time of the normoxia culture is preferably 1-600 min, more preferably 5-30 min, and still more preferably 10 min.
最后,所述细胞在二元炔基化合物溶液中培养结束后,弃去培养液,加入培养基,继续常氧培养,实现乏氧响应型炔-胺点击聚合的细胞内聚合。Finally, after the cells are cultured in the binary alkynyl compound solution, the culture medium is discarded, the culture medium is added, and the normoxia culture is continued to realize the intracellular polymerization of the hypoxia-responsive alkyne-amine click polymerization.
在本发明中,弃去培养液后还优选采用PBS磷酸缓冲盐溶液洗涤细胞。In the present invention, after the culture medium is discarded, the cells are preferably washed with PBS phosphate buffered saline.
在本发明中,所述PBS磷酸缓冲盐溶液的用量优选为0.5~1.5ml,进一步优选为1ml。In the present invention, the dosage of the PBS phosphate buffered saline solution is preferably 0.5-1.5 ml, more preferably 1 ml.
在本发明中,所述PBS磷酸缓冲盐溶液洗涤的次数优选为2~4次,进一步优选为3次。In the present invention, the number of times of washing with the PBS phosphate buffered saline solution is preferably 2 to 4 times, more preferably 3 times.
在本发明中,所述培养基优选为PBS磷酸缓冲盐溶液、HEPES缓冲液、DMEM细胞培养基和1640细胞培养基中的一种或几种,进一步优选为PBS磷酸缓冲盐溶液或DMEM细胞培养基,再进一步优选为含10%胎牛血清的DMEM细胞培养基。In the present invention, the culture medium is preferably one or more of PBS phosphate buffered saline, HEPES buffer, DMEM cell culture medium and 1640 cell culture medium, more preferably PBS phosphate buffered saline or DMEM cell culture The base is further preferably DMEM cell culture medium containing 10% fetal bovine serum.
在本发明中,所述常氧培养的温度优选为4~37℃,进一步优选为37℃。In the present invention, the temperature of the normoxia culture is preferably 4 to 37°C, more preferably 37°C.
在本发明中,所述常氧培养的时间优选为1~600min,进一步优选为60~180min,再进一步优选为120min。In the present invention, the time of the normoxia culture is preferably 1-600 min, more preferably 60-180 min, and still more preferably 120 min.
本发明还提供了一种所述的乏氧响应型炔-胺点击聚合的细胞内聚合方法实现细胞荧光成像的应用。The invention also provides an application of the hypoxia-responsive intracellular polymerization method of alkyne-amine click polymerization to realize cell fluorescence imaging.
下面结合实施例对本发明提供的技术方案进行详细的说明,但是不能把它们理解为对本发明保护范围的限定。The technical solutions provided by the present invention will be described in detail below with reference to the embodiments, but they should not be construed as limiting the protection scope of the present invention.
实施例1Example 1
将细胞密度长至80%的HeLa细胞进行消化、重悬于新鲜的DMEM(10%胎牛血清)培养基中,并稀释至1.5×105个/mL,每个激光共聚焦培养皿中接种1mL,培养至细胞贴壁后,加入浓度为150μM芳香族二元硝基化合物1溶液(溶剂为含10%胎牛血清的DMEM培养基),置于37℃、5%O2下乏氧培养2h;乏氧培养结束后,在室温(20℃)下弃去培养液,并用1ml PBS磷酸缓冲盐溶液将细胞小心洗涤3次,然后将洗涤后的细胞加入浓度为10μM的二元炔基化合物M2溶液(溶剂为PBS),置于37℃下常氧(21%O2)培养10min;常氧培养结束后,在室温(20℃)下弃去培养液,并用1ml PBS磷酸缓冲盐溶液将细胞小心洗涤3次,然后在洗涤后的细胞中加入新鲜的10%胎牛血清的DMEM培养基继续在37℃下常氧培养2h,完成聚合。HeLa cells up to 80% cell density were digested, resuspended in fresh DMEM (10% fetal bovine serum) medium, and diluted to 1.5 x 105 cells/mL, inoculated in each confocal dish 1mL, after culturing until the cells adhered, add 150μM aromatic
其中,芳香族二元硝基化合物1为:(即式Ⅰ中R3为16所示的结构式、R4为氧原子时的化合物),二元炔基化合物M2为(即式Ⅲ中R1为8所示的结构式、R2为氢原子时的化合物)。Wherein, the aromatic
所述乏氧响应过程由硝基还原酶(NTR)和辅酶(NAD(P)H)一起作用将硝基基团还原为胺基基团实现(得到芳香族二元硝基化合物M1),响应过程如式(一):The hypoxia response process is realized by the reduction of the nitro group to the amine group by the action of nitroreductase (NTR) and coenzyme (NAD(P)H) (to obtain an aromatic binary nitro compound M1), and the response is The process is as formula (1):
所述炔类单体(M2)与二元胺(M1)经点击氢胺化聚合反应,得到单体P1,反应方程式如式(二):The acetylenic monomer (M2) and the diamine (M1) are subjected to the click hydrogen amination polymerization reaction to obtain the monomer P1, and the reaction equation is as formula (2):
其中,化合物M1的合成方法可按照已公开文献中(Macromolecules 1997,30:3547-3552)的合成方法合成;化合物M2的合成合成方法可按照已公开文献中(Macromolecules 2020,53:2516-2525)。Among them, the synthesis method of compound M1 can be synthesized according to the synthesis method in the published literature (Macromolecules 1997, 30:3547-3552); the synthesis method of compound M2 can be synthesized according to the synthesis method in the published literature (Macromolecules 2020, 53:2516-2525) .
实施例2Example 2
检测实施例1中芳香族二元硝基化合物1和芳香族二元胺基化合物M1的发光情况,结果如图1所示。从图1可以看出,化合物M1具有较强的荧光,而化合物1几乎不发光。表明二元硝基化合物在转化为二元胺基化合物之前,不能发生荧光信号的“点亮”。The luminescence of the aromatic
实施例3Example 3
将浓度为1.5×105个/mL的HeLa细胞,取1mL加入激光共聚焦培养皿中,培养至细胞贴壁后,加入浓度为150μM的芳香族二元硝基化合物1溶液(溶剂为含10%胎牛血清的DMEM培养基),在37℃下分别在常氧(21%O2)、5%O2、1%O2以及5%O2+双香豆素(硝基还原酶抑制剂)条件下进行培养,培养结束后,在室温(20℃)下弃去培养液,并用1ml PBS磷酸缓冲盐溶液将细胞小心洗涤3次,然后将洗涤后的细胞加浓度为10μM的二元炔基化合物M2溶液(溶剂为PBS),然后均在37℃下进行常氧培养,常氧培养结束后,在室温(20℃)下弃去培养液,并用1ml PBS磷酸缓冲盐溶液将细胞小心洗涤3次,然后在洗涤后的细胞中加入新鲜的含10%胎牛血清的DMEM培养基,继续在37℃下进行常氧培养,完成聚合。检测各组细胞荧光成像。结果如图2所示。Add 1 mL of HeLa cells with a concentration of 1.5 × 10 5 cells/mL to a laser confocal culture dish, and culture until the cells adhere to the wall. % fetal bovine serum in DMEM medium) at 37°C in normoxia (21% O 2 ), 5% O 2 , 1% O 2 and 5% O 2 + dicoumarin (nitroreductase inhibitory After incubation, the culture medium was discarded at room temperature (20°C), and the cells were carefully washed 3 times with 1 ml of PBS phosphate buffered saline solution, and then the washed cells were added with a concentration of 10 μM binary Alkynyl compound M2 solution (the solvent is PBS), and then both were incubated in normoxia at 37°C. After the normoxic incubation, the culture medium was discarded at room temperature (20°C), and the cells were carefully plated with 1 ml of PBS phosphate buffered saline. After washing 3 times, fresh DMEM medium containing 10% fetal bovine serum was added to the washed cells, and the cells were incubated under normoxia at 37°C to complete the polymerization. Fluorescence imaging of cells in each group was detected. The results are shown in Figure 2.
从图2中可以看出,在常氧环境下(21%O2)用化合物1处理的HeLa细胞检测不到荧光信号,只有在乏氧条件下(5%O2、1%O2)才能检测到荧光信号。硝基还原酶被抑制后(TPE-2NO2-双香豆素组)发现荧光也被明显抑制。表明化合物1只有在乏氧环境下才能经硝基还原酶被还原为化合物M1,实现细胞荧光成像。It can be seen from Figure 2 that under normoxic conditions (21% O 2 ) HeLa cells treated with
实施例4Example 4
测定正常细胞L929和癌细胞4T1、A549、HeLa用化合物1在乏氧条件下处理后的荧光成像情况(各处理的具体实验步骤同实施例1)。结果如图3所示。The fluorescence imaging of normal cells L929 and cancer cells 4T1, A549 and HeLa treated with
图3中相同条件下(37℃,5%O2),癌细胞4T1、A549、HeLa都具有明显的荧光成像,说明该响应过程还可发生在癌细胞4T1、A549中,对癌细胞具有普适性。同时正常细胞L929的荧光较弱,表明本发明的细胞内乏氧响应聚合反应对正常细胞无明显作用。In Figure 3, under the same conditions (37°C, 5% O 2 ), cancer cells 4T1, A549, and HeLa all have obvious fluorescence imaging, indicating that this response process can also occur in cancer cells 4T1 and A549, and has a general effect on cancer cells. suitability. Meanwhile, the fluorescence of normal cell L929 is weak, indicating that the intracellular hypoxia-responsive polymerization reaction of the present invention has no obvious effect on normal cells.
实施例5Example 5
观察有无化合物M2对乏氧响应型细胞内聚合的影响。The effect of compound M2 on hypoxia-responsive intracellular aggregation was observed.
无化合物M2的处理:将浓度为1.5×105个/mL的HeLa细胞,取1mL加入激光共聚焦培养皿中,培养至细胞贴壁后,加入浓度为150μM芳香族二元硝基化合物1溶液(溶剂为含10%胎牛血清的DMEM培养基),置于37℃、5%O2下乏氧培养2h,乏氧培养结束后,在室温(20℃)下弃去培养液,并用1ml PBS磷酸缓冲盐溶液将细胞小心洗涤3次,然后在洗涤后的细胞中加入新鲜的含10%胎牛血清的DMEM培养基在37℃下进行常氧培养2h。然后进行共聚焦细胞荧光成像。Treatment without compound M2:
有化合物M2的处理:将浓度为1.5×105个/mL的HeLa细胞,取1mL加入激光共聚焦培养皿中,培养至细胞贴壁后,浓度为150μM芳香族二元硝基化合物1溶液(溶剂为含10%胎牛血清的DMEM培养基),置于37℃、5%O2下乏氧培养2h,乏氧培养结束后,在室温(20℃)下弃去培养液,并用1ml PBS磷酸缓冲盐溶液将细胞小心洗涤3次,然后将洗涤后的细胞加入浓度为10μM的二元炔基化合物M2的溶液(溶剂为PBS),置于37℃下进行常氧培养10min;常氧培养结束后,在室温(20℃)下弃去培养液,并用1ml PBS磷酸缓冲盐溶液将细胞小心洗涤3次,然后在洗涤后的细胞中加入新鲜的含10%胎牛血清的DMEM培养基继续在37℃下常氧培养2h,完成聚合。然后进行共聚焦细胞荧光成像进行比较。结果如图4所示。图4中(A)为不加入化合物M2的荧光成像,图4中(B)为加入化合物M2的荧光成像。Treatment with compound M2:
可以看出图4的(A)中由于小分子易排出的原因,硝基还原为胺基后的荧光很快消失;而(B)中加入化合物M2后,细胞内荧光得到固定。这得益于炔-胺聚合反应的高效性,引入化合物M2可以与细胞内原位生成的化合物M1实现乏氧响应型细胞内聚合生成单体P1,从而固定荧光小分子(即化合物M1)实现细胞内的稳定荧光成像。It can be seen that in (A) of Figure 4, due to the easy expulsion of small molecules, the fluorescence after the reduction of the nitro group to the amine group quickly disappeared; while in (B), the intracellular fluorescence was fixed after the addition of compound M2. Thanks to the high efficiency of alkyne-amine polymerization, the introduction of compound M2 can achieve hypoxia-responsive intracellular polymerization with compound M1 generated in situ in cells to generate monomer P1, thereby immobilizing small fluorescent molecules (ie compound M1) to achieve Intracellular Stable Fluorescence Imaging.
实施例6Example 6
采用MTT法测试细胞存活率。其检测原理为由MTT试剂将生长状态良好的细胞中的琥珀酸脱氢酶(位于线粒体)还原成不溶于水却溶于DMSO的紫色结晶,通过检测其在570nm处的吸收值反应细胞的存活状态。Cell viability was tested by MTT method. The detection principle is that succinate dehydrogenase (located in mitochondria) in well-grown cells is reduced by MTT reagent to purple crystals that are insoluble in water but soluble in DMSO, and the cell survival is reflected by detecting its absorption value at 570nm. state.
将1×105个/ml的HeLa细胞悬液加入96孔板中,每孔加入100μl,即每孔1万个细胞,将铺满细胞的96孔板放入培养箱(37℃)过夜,第二天检查细胞贴壁良好后,备用。Add 1×10 5 cells/ml of HeLa cell suspension to a 96-well plate, add 100 μl to each well, that is, 10,000 cells per well, and place the 96-well plate confluent with cells into an incubator (37°C) overnight. The next day, after checking that the cells adhere well, set aside.
TPE-2NO2(化合物1)乏氧下的毒性测试:取贴壁良好的96孔细胞板,弃去培养液,分别加入不同浓度(50、100、150、200、250μM)的化合物1溶液(溶剂为含10%胎牛血清的DMEM培养基),100μl/孔,在37℃,5%O2条件下孵育2h,然后弃去培养液,加入DMEM(10%胎牛血清)培养基,1ml/孔,继续在37℃常氧条件下孵育22h。然后弃去培养液,加入10μg/ml的MTT溶液,100μl/孔,继续在在37℃常氧条件下孵育4h,这时皿底有明显紫色结晶生成,再弃去培养液,没孔加入100μl DMSO进行溶解,然后置于酶标仪测试其在570nm的吸收值并将测得数据进行处理。Toxicity test of TPE-2NO 2 (compound 1) under hypoxia: take a well-adhered 96-well cell plate, discard the culture medium, and add
活化炔(化合物M2)的毒性测试:取贴壁良好的96孔细胞板,弃去培养液加入不同浓度(1、2、4、8、16μM)的化合物M2溶液(溶剂为PBS),100μl/孔,在37℃,20%O2条件下孵育10min,然后弃去培养液,加入DMEM(10%胎牛血清)培养基,1ml/孔,继续在37℃,常氧条件下孵育24h。然后弃去培养液,加入10μg/ml的MTT溶液,100μl/孔,继续在37℃,常氧条件下中孵育4h,这时皿底有明显紫色结晶生成,再弃去培养液,每孔加入100μl的DMSO进行溶解,然后置于酶标仪测试其在570nm的吸收值并将测得数据进行处理。Toxicity test of activated alkyne (compound M2): take a well-adhered 96-well cell plate, discard the culture medium and add compound M2 solution (solvent is PBS) of different concentrations (1, 2, 4, 8, 16 μM), 100 μl/ Well, incubate for 10 min at 37°C under 20% O 2 conditions, then discard the culture medium, add DMEM (10% fetal bovine serum) medium, 1ml/well, and continue to incubate at 37°C under normoxia for 24h. Then discard the culture medium, add 10 μg/ml MTT solution, 100 μl/well, and continue to incubate at 37°C for 4 hours under normoxia. At this time, obvious purple crystals are formed at the bottom of the dish, then discard the culture medium and add 100 μl of DMSO was dissolved, and then placed in a microplate reader to test its absorption value at 570 nm and the measured data were processed.
细胞内聚合毒性测试:取贴壁良好的96孔细胞板,弃去培养液分别加入浓度150μM的化合物1(100μl/孔),在37℃,5%O2条件下孵育2h,然后弃去培养液并PBS小心清洗三次,弃去培养液分别加入不同浓度(1、2、4、8、16μM)的化合物M2溶液(溶剂为PBS),100μl/孔,在37℃常氧条件下孵育10min,然后弃去培养液,继续在37℃常氧条件下孵育22h。然后弃去培养液,加入10μg/ml的MTT溶液,100μl/孔,继续37℃,常氧孵育4h,这时皿底有明显紫色结晶生成,再弃去培养液,没孔加入100μl的DMSO进行溶解,然后置于酶标仪测试其在570nm的吸收值并将测得数据进行处理。Intracellular aggregation toxicity test: take a well-adhered 96-well cell plate, discard the culture medium, add compound 1 (100 μl/well) at a concentration of 150 μM, incubate at 37°C, 5% O 2 for 2 h, then discard the culture The solution was carefully washed three times with PBS, the culture medium was discarded, and different concentrations (1, 2, 4, 8, 16 μM) of compound M2 solution (solvent in PBS) were added, 100 μl/well, and incubated at 37 °C under normoxia for 10 min. Then the culture medium was discarded, and the incubation was continued at 37°C under normoxia for 22h. Then discard the culture medium, add 10 μg/ml MTT solution, 100 μl/well, continue to incubate at 37°C for 4 h in normoxia, at this time, obvious purple crystals are formed at the bottom of the dish, then discard the culture medium, and add 100 μl of DMSO to every hole. Dissolved, and then placed in a microplate reader to test its absorption value at 570nm and processed the measured data.
根据以下等式评估细胞活力比(VR):The cell viability ratio (VR) was estimated according to the following equation:
其中A0是没有任何药物的细胞的吸光度,A是孵育待测样品的细胞的吸光度。where A 0 is the absorbance of cells without any drug, and A is the absorbance of cells incubated with the sample to be tested.
结果如图5~7所示。其中图5为化合物1对HaLe细胞的毒性测试结果,图6为化合物M2对HaLe细胞的毒性测试结果,图7为乏氧响应型细胞内聚合对HaLe细胞的毒性测试结果。The results are shown in FIGS. 5 to 7 . Figure 5 shows the toxicity test results of
结果表明:TPE-2NO2经细胞内硝基还原酶还原后原位生成的TPE-2NH2与羰基活化端炔发生炔-胺点击聚合后对HaLe细胞产生较强的毒性作用,导致细胞存活率降低。而单独的化合物1和化合物M2对HaLe细胞没有产生毒性作用,细胞存活率较高。The results showed that the alkyne-amine click polymerization of TPE-2NH 2 generated in situ after the reduction of TPE-2NO 2 by intracellular nitroreductase and carbonyl-activated terminal alkynes had a strong toxic effect on HaLe cells, resulting in cell viability. reduce. However,
以细胞内聚合毒性测试中的细胞作为对照组,以没有任何药物的细胞作为空白组,进行电镜扫描,结果如图8所示。从图8中可以看出与空白组细胞相比,实验组细胞结构破坏严重。Taking the cells in the intracellular aggregation toxicity test as the control group, and taking the cells without any drug as the blank group, electron microscope scanning was performed, and the results are shown in Fig. 8 . It can be seen from Figure 8 that compared with the cells of the blank group, the cell structure of the experimental group was severely damaged.
以细胞内聚合毒性测试中的细胞作为对照组,以没有任何药物的细胞作为空白组,进行冷冻电镜扫描,结果如图9所示。从图9中可以看出实验组中内质网结构的严重破坏。Taking the cells in the intracellular aggregation toxicity test as the control group, and taking the cells without any drug as the blank group, cryo-electron microscopy was performed, and the results are shown in Figure 9. The severe disruption of the endoplasmic reticulum structure in the experimental group can be seen from Figure 9.
实施例7Example 7
HeLa细胞在共焦成像皿中贴壁生长。在37℃、5%O2下,HeLa细胞先用浓度为150μM的化合物1溶液(溶剂为含10%胎牛血清的DMEM培养基)孵育2h,弃去培养液,用室温(20℃)1ml PBS将细胞小心洗涤3次,然后加入浓度为10μM的化合物2溶液(溶剂为PBS)。在37℃下常氧孵育10min,弃去培养液,然后加入新鲜的DMEM(10%FBS)并再在37℃常氧条件下孵育24h,紧接着将细胞在室温下用4%多聚甲醛固定15min,在室温(20℃)下用0.2%Triton X-100透化15min,然后用0.2%PBS-T中的5%脱脂牛奶(将0.5g脱脂奶粉+20μl的Tween20一起溶于10ml的PBS缓冲液制备得到)封闭1h。将细胞与抗CRT抗体在4℃下孵育过夜,然后在室温下与Alexa488二次抗体进一步孵育2h。最后,在PBS中与Hoechst(10μg/ml)一起孵育5min。然后使用CLSM对细胞进行成像。对于Alexa488,激发波长为488nm,发射滤光片为500~540nm;对于Hoechst,激发波长为405nm,发射滤光片为430~478nm。HeLa cells were grown adherently in confocal imaging dishes. At 37°C and 5% O 2 , HeLa cells were first incubated with 150
对上述处理后的细胞进行共聚焦荧光成像实验,同时对没有经过加药处理的HeLa细胞也进行上述处理,作为对照组。结果如图10所示,从图10中可以看出,实验组有荧光出现,表明其钙网蛋白具有外翻现象。Confocal fluorescence imaging experiments were performed on the above-treated cells, and at the same time, the above-mentioned treatments were also performed on HeLa cells without drug treatment, as a control group. The results are shown in Fig. 10. It can be seen from Fig. 10 that fluorescence appeared in the experimental group, indicating that its calreticulin had an eversion phenomenon.
实施例8Example 8
HeLa细胞在共焦成像皿中贴壁生长。在37℃、5%O2下,HeLa细胞先用浓度为150μM的化合物1溶液(溶剂为含10%胎牛血清的DMEM培养基)孵育2h,弃去培养液,用室温(20℃)1ml PBS将细胞小心洗涤3次,然后加入浓度为10μM的化合物2溶液(溶剂为PBS)。在37℃下常氧孵育10min,之后与新鲜DMEM(10%FBS)培养基继续在37℃常氧条件下孵育120min,之后再用Annexin V-FITC(1/200稀释)和5μg/mL PI与其共孵育30min,孵育完成后进行共聚焦荧光成像。Annexin V-FITC的激发波长为488nm,发射滤光片波长为490~557nm;PI激发为543nm,发射滤光片为557~680nm。HeLa cells were grown adherently in confocal imaging dishes. At 37°C and 5% O 2 , HeLa cells were first incubated with 150
对上述处理后的细胞进行共聚焦荧光成像实验,同时对没有经过加药处理的HeLa细胞也进行上述处理,作为对照组。结果如图11所示,实验组细胞发生凋亡。Confocal fluorescence imaging experiments were performed on the above-treated cells, and at the same time, the above-mentioned treatments were also performed on HeLa cells without drug treatment, as a control group. The results are shown in Figure 11, the cells in the experimental group undergo apoptosis.
实施例9Example 9
实验所用BALB/C小鼠(鼠龄6~8周)均购于广东省动物中心,实验开展于华南农业大学实验动物中心。小鼠进动物中心一周完成常规病检并完全适应新的环境后开始开展实验。BALB/C mice (6-8 weeks old) used in the experiments were purchased from the Guangdong Animal Center, and the experiments were carried out in the Laboratory Animal Center of South China Agricultural University. The mice entered the animal center for one week to complete routine medical examinations and fully adapt to the new environment before starting the experiment.
1、将小白鼠分成五组,每组4只,分为实验组和对照组。1. Divide the mice into five groups, with 4 mice in each group, divided into the experimental group and the control group.
2、麻药使用5%水合氯醛,每只小鼠腹腔注射麻药100μL,等待昏迷;2. Use 5% chloral hydrate as an anesthetic, inject 100 μL of anesthetic into each mouse intraperitoneally, and wait for coma;
3、分别进行脱毛,清洗,干燥,每组每只接种100μL(1×107)4T1肿瘤细胞;3. Depilate, wash and dry respectively, and inoculate 100 μL (1×10 7 ) 4T1 tumor cells in each group;
4、等待肿瘤长成期望尺寸50mm3时使用;4. Use when the tumor grows to the desired size of 50mm3 ;
5、药物注射采用对皮下肿瘤部位进行药物原位注射,其中,实验组1注射化合物1和化合物M2,注射时先注射25μL/50mm3的化合物1(浓度为10mM/PBS),间隔6h后,注射25μL/50mm3的化合物M2(浓度为1mM/PBS);实验组2、3、4分别注射25μL/50mm3化合物1(浓度为10mM/PBS)、25μL/50mm3化合物M2(浓度为1mM/PBS)、25μL/50mm3化合物M1(浓度为1mM/PBS);对照组注射25μL/50mm3的PBS。5. In situ injection of drugs into subcutaneous tumor sites, among which,
6、每隔一天,测量小鼠的体重和肿瘤的体积,记录15天的数据。结果如图12、13所示。6. Every other day, measure the body weight and tumor volume of the mice, and record the data for 15 days. The results are shown in Figures 12 and 13.
从图12中可以看出,各组肿瘤体积均以不同程度上升且最终高于初始肿瘤体积,与PBS处理相比,化合物1和化合物M1处理对肿瘤生长的抑制作用可以忽略不计,M2处理也有与PBS相似的肿瘤生长曲线,值得注意的是,化合物1/M2治疗组(实验组1)的抗肿瘤作用最为显着,肿瘤生长速度非常缓慢。As can be seen from Figure 12, the tumor volume in each group increased to varying degrees and was finally higher than the initial tumor volume. Compared with PBS treatment, the inhibitory effect of
从图13中可以看出,在治疗过程中,各组小鼠体积均没有下降,反而表现出轻微上升的趋势,缓慢上升的小鼠体重表明各种治疗方式都具有良好的生物相容性。As can be seen from Figure 13, during the treatment process, the volume of mice in each group did not decrease, but showed a slight upward trend. The slowly rising body weight of mice indicated that various treatment methods had good biocompatibility.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above are only the preferred embodiments of the present invention. It should be pointed out that for those skilled in the art, without departing from the principles of the present invention, several improvements and modifications can be made. It should be regarded as the protection scope of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210278516.7A CN114736938A (en) | 2022-03-21 | 2022-03-21 | A hypoxia-responsive alkyne-amine click polymerization method for intracellular polymerization and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210278516.7A CN114736938A (en) | 2022-03-21 | 2022-03-21 | A hypoxia-responsive alkyne-amine click polymerization method for intracellular polymerization and its application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114736938A true CN114736938A (en) | 2022-07-12 |
Family
ID=82276622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210278516.7A Pending CN114736938A (en) | 2022-03-21 | 2022-03-21 | A hypoxia-responsive alkyne-amine click polymerization method for intracellular polymerization and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114736938A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105884734A (en) * | 2016-06-24 | 2016-08-24 | 济南大学 | Double-photon fluorescent probe capable of fast detecting nitroreductase |
CN109554411A (en) * | 2018-11-21 | 2019-04-02 | 华南理工大学 | The intracellular polymerization of polymerization is clicked based on alkynes-amine |
CN111875597A (en) * | 2020-08-05 | 2020-11-03 | 国家纳米科学中心 | Hypoxic fluorescent imaging probe and preparation method and application thereof |
US20210048393A1 (en) * | 2018-11-30 | 2021-02-18 | South China University Of Technology | Fluorescent probe for detecting nitroreductase and preparation method and use thereof in enzymatic reaction |
CN112745303A (en) * | 2019-10-30 | 2021-05-04 | 南京大学 | Hypoxic fluorescent probe and application thereof |
CN113563279A (en) * | 2021-08-25 | 2021-10-29 | 安徽大学 | Two-photon fluorescent probe for detecting nitroreductase and preparation method and application thereof |
-
2022
- 2022-03-21 CN CN202210278516.7A patent/CN114736938A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105884734A (en) * | 2016-06-24 | 2016-08-24 | 济南大学 | Double-photon fluorescent probe capable of fast detecting nitroreductase |
CN109554411A (en) * | 2018-11-21 | 2019-04-02 | 华南理工大学 | The intracellular polymerization of polymerization is clicked based on alkynes-amine |
US20210048393A1 (en) * | 2018-11-30 | 2021-02-18 | South China University Of Technology | Fluorescent probe for detecting nitroreductase and preparation method and use thereof in enzymatic reaction |
CN112745303A (en) * | 2019-10-30 | 2021-05-04 | 南京大学 | Hypoxic fluorescent probe and application thereof |
CN111875597A (en) * | 2020-08-05 | 2020-11-03 | 国家纳米科学中心 | Hypoxic fluorescent imaging probe and preparation method and application thereof |
CN113563279A (en) * | 2021-08-25 | 2021-10-29 | 安徽大学 | Two-photon fluorescent probe for detecting nitroreductase and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021103700A1 (en) | Nitroreductase responsive hypoxia probe compound, and preparation and application thereof | |
CN106749153B (en) | Specific fluorescent probe of nitroreductase, preparation thereof and application thereof in tumor targeted fluorescence imaging and monitoring of tumor hypoxia degree | |
CN111559991B (en) | Preparation method and application of naphthylamine compound and salt thereof | |
CN108794475B (en) | Fluorescent carbon dots for sensing alcohol, preparation method and application thereof | |
CN108822081B (en) | Fluorescent probe for simultaneously detecting mitochondria and DNA | |
CN108558967B (en) | A kind of cell membrane imaging fluorescent probe and its application | |
CN104861039B (en) | A kind of phthalocyanine compound, preparation method and the application as single, double photon fluorescence probe in cancer targeting and mitochondrial markers | |
CN113444035A (en) | Naphthyl urea compounds with brand new chemical structure and preparation method and application thereof | |
CN111875604A (en) | Fluorescent compound of beta-carboline onium salt for mitochondrial targeting and photodynamic therapy and preparation method and application thereof | |
WO2022171044A1 (en) | Oxa-azaspiro compound, salt form thereof and crystal form thereof | |
WO2019227528A1 (en) | Fluorescently labeled polysaccharide, preparation method therefor, and use thereof | |
CN113387892A (en) | Imidazole heterocyclic derivative containing nitrogen mustard and preparation method and application thereof | |
CN102443018B (en) | Fluorescence-labeled O6-benzylguanine and its preparation and application | |
CN115353460B (en) | Application of a phenol-containing ketone-salicylicaldehyde hydrazide compound in endoplasmic reticulum imaging | |
CN114685571B (en) | Oligosaccharide fluorescent marker and preparation method and application thereof | |
CN114736938A (en) | A hypoxia-responsive alkyne-amine click polymerization method for intracellular polymerization and its application | |
CN114805262A (en) | Viscosity and polarity response type platform fluorescent probe, hydrogen sulfide detection fluorescent probe, synthesis process and application thereof | |
CN102010508B (en) | Cationic polymer and preparation method and application thereof | |
CN115011139B (en) | A kind of non-heavy atom photosensitizer based on cyanine dye structure and its synthesis method and application | |
CN111518546A (en) | Hypoxic microenvironment response fluorescent probe and preparation method and application thereof | |
CN117603206A (en) | Mitochondrial fluorescent probe and preparation method and application thereof | |
CN109913206A (en) | A kind of RNA fluorescent probe and its preparation method and application | |
CN111675919B (en) | PCP and application thereof in preparing antitumor drugs | |
CN111423448B (en) | Stemona alkaloid skeleton-based small-molecule probe and preparation method and application thereof | |
CN113121488B (en) | A kind of fluorescent probe molecule for detecting azoreductase based on coumarin derivatives, preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220712 |
|
RJ01 | Rejection of invention patent application after publication |